Low T Lawsuits: Exploring Your Rights To File

September 24, 2015 – – Banville Law reports that millions of men across the United States are using testosterone therapy to treat something termed “low-T.” Low T is used to describe symptoms associated with the natural decline in testosterone all men experience as they age.

As testosterone declines, it can produce some unwelcome side effects, such as loss of libido, muscle mass, and bone density, and weight gain, irritability, fatigue or insomnia. While this is a normal part of aging, it is alleged that manufacturers of low testosterone therapies approved for treatment of hypogonadism, have also been targeting these men.

Current legal claims surrounding the controversial treatments state that, especially for men without hypogonadism, these low t drugs can cause several health risks, ranging from heart attacks, blood clots, strokes, and death.

On January 31st of 2014, the United States Food and Drug Administration made announcements stating that it would begin investigating the prescription low testosterone products. This investigation was spurred after two studies were published linking low testosterone therapy treatments to an increased risk of pulmonary embolism, deep vein thrombosis, heart attacks, strokes, and death.

During one of these studies, the National Cancer Institute profiled more than 55,000 men with lowered testosterone levels. It was noted that when some of these men used low testosterone drugs, they were at increased risk of suffering from cardiac problems including heart attacks. Additionally, it was noted that men ages 65 and older seemed to double their heart attack risk within only the first three months of using their low testosterone treatments.

Low Testosterone therapy drugs come in a variety of forms, including injections, gels/creams, and pills. They also come under many brand names and are marketed through several manufacturers. AndroGel is the most commonly used low T medication, but there are several others to be aware of: Androderm, Axiron, Bio-T-Gel, Delatestryl, Fortesta, Striant, Testim, and Testopel.

Currently, over 2,500 legal claims have been filed against the manufacturers of many of these treatments. The claims have been consolidated to form an MDL (or Multidistrict Litigation) in the U.S. District Court for the Northern District of Illinois. Discovery is ongoing for the MDL and dates for bellwether trials will soon be set. They will be overseen by the Honorable Judge Matthew F. Kennelly.

Anyone who has suffered serious health complications after being prescribed a low testosterone treatment may be entitled to a lawsuit and compensation. Laurence Banville, Esq. of Banville Law is currently working to help individuals who would like to explore their legal options. He also sponsors LowTestosteroneCase.com, where people can find more details regarding low testosterone lawsuits and their rights.

Call 917-809-6595 anytime to speak with Laurence Banville, Esq. directly and get the assistance you deserve.

###

Contact Banville Law:

Laurence Banville, Esq.
888-478-9711
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60004364